Until now, no similar enzyme has been identified for covalent FAD attachment. Instead, an autocatalytic mechanism was proposed based on suggestive data from heterologously expressed bovine monoamine oxidase A. 10 In contrast, covalent FAD attachment to Sdh1 appears to be dependent on additional protein factors. 11 Using in vitro translated Sdh1 precursor and differentially treated mitochondria, Sdh1 flavination was shown to require matrix import, ATP and at least one additional protein. 11 We would suggest that Sdh5 is the necessary matrix protein suggested by these earlier experiments.
The question remains, however, whether Sdh5 is the enzyme responsible for the chemistry of FAD attachment or simply a chaperone maintaining Sdh1 in a conformation that is susceptible to autocatalytic FAD attachment. This is a very difficult question and the answer remains to be determined. Four observations from the published work, 4 however, would
We have recently described the studies of one such protein that we named Sdh5. 4 We showed that Sdh5 physically interacts with the catalytic subunit of succinate dehydrogenase (SDH), a component of both the tricarboxylic acid cycle and electron transport chain. Sdh5 is necessary and sufficient for FAD cofactor conjugation (flavination) of Sdh1, which is required for SDH activity. The human SDH5 ortholog similarly interacts with human SDHA (Sdh1 ortholog) and is able to complement the yeast sdh5∆ mutant phenotype and rescue Sdh1 flavination, suggesting functional conservation. Based on the causal relationship of loss of SDH activity with a rare neuroendocrine tumor called paraganglioma (PGL), we sought to determine whether mutations in human SDH5 might be associated with some forms of paraganglioma. Indeed, we discovered that one familial form of paraganglioma, PGL2, is caused by a G78R mutation in hSDH5. The G78R mutant of hSDH5 was completely inactive in functional studies and tumors derived from PGL2 patients exhibited a near complete loss of SDHA flavination. The gene that we identified as SDH5 (C11orf79/FLJ20487) was previously predicted as one of the possible PGL2 genes as a result of elegant proteomics and bioinformatics. 5 The assembly of membrane bound electron transport complexes is a complicated multi-step process involving assembly of multiple subunits as well as insertion of cofactors such as FAD, heme and metals. This complexity is illustrated by cytochrome c oxidase (Complex IV) assembly, which requires more than 30 accessory proteins. 6 In contrast, only one assembly factor had been reported for Complex II, the yeast Tcm62 protein that Mitochondria are unique, dynamic and complex organelles that play vital roles in many aspects of cellular function. As a result, mitochondrial dysfunction is tightly coupled with a variety of human diseases. In fact, about 20% of predicted human mitochondrial proteins have been implicated in one or more hereditary diseases. 1, 2 The best current inventory of mammalian mitochondrial resident proteins consists of 1098 proteins.
3 Surprisingly, nearly 300 proteins in this compendium are essentially uncharacterized. Among them, many are highly conserved throughout eukarya, indicating their functional importance. Presumably, the quarter of the mitochondrial proteome that is uncharacterized, especially those with high degree of conservation, contains many human disease genes that await discovery.
Making the disease connection would be greatly facilitated by an understanding of the biochemical and physiological function of these proteins. Therefore, we initiated a project to understand the function of a subset of these proteins. We chose to use yeast as the primary model system for three reasons. First, the yeast S. cerevisiae is a tractable and facile genetic and biochemical system. Second, mitochondrial biology is cell-autonomous and highly conserved from yeast to humans. Finally, yeast can survive the complete loss of respiration, due to their ability to generate ATP from fermentation. This is very important for genetic analysis of proteins that are essential for respiration, deletion of which would be lethal in other organisms. The strategy we decided to employ was to study these genes initially using yeast. As it became appropriate, we intended to confirm our findings in higher eukaryotes and eventually move to human studies. of Sdh5 (surrounding the G78 position) is highly basic in all species (Fig. S1) . It is possible that this region participates in an interaction with the negatively charged pyrophosphate moiety of FAD during the attachment reaction.
Whatever the exact role of Sdh5 in Sdh1 flavination, three observations from the published work suggest that it plays that role very specifically. First, in the absence of Sdh1, the Sdh5 protein fails to accumulate (Fig. S1F) . The fact that loss of Sdh1 leads to a complete loss of Sdh5, presumably through protein destabilization and degradation, suggests that Sdh1 is an obligate binding partner of Sdh5. This intimate relationship implies a high degree of specificity for Sdh5 function. Second, Sdh5 overexpression in the flx1∆ mutant strain lacking the mitochondrial FAD transporter enhanced Sdh1 flavination (Fig. S3B) , but failed to rescue the glycerol growth defect of the flx1∆ mutant strain (Fig. S11) , which is presumably caused by deficiency of FAD occupancy in other flavoproteins. Finally, covalent FAD attachment to the two other mitochondrial proteins visualized in the fluorescent gel assay was completely normal in the suggest that Sdh5 does not act simply as a general chaperone. First, in addition to the myriad of native chaperones in both the mitochondrial matrix of S. cerevisiae and in E. coli, co-expression of Sdh2, a clear Sdh1 binding partner, is completely unable to support flavination of Sdh1 in either yeast (Fig. S10) or bacteria (Fig.  S3C) . Second, if hSDH5 were acting simply as a chaperone to promote FAD incorporation, it is likely that the hSDH5-associated population of SDHA would NOT be flavinated. We found, however, that the hSDH5-associated SDHA has exactly the same normalized FAD signal as the hSDH5-unbound SDHA (Fig.  S4C) . Third, we conducted an extensive high-copy suppressor screen for rescue of the sdh5∆ glycerol growth defect using a yeast genomic library. We recovered many independent SDH5-containing plasmids, but found no additional genes that enabled bypass of SDH5. This is suggestive of a fairly specific role for Sdh5 that cannot be compensated by increased general chaperone activity (or by other means). Fourth, the sequence of Sdh5 may be suggestive of a direct relationship with FAD. The most highly conserved region sdh5∆ mutant and it was not affected by Sdh5 overexpression (Fig. S3A and B) .
In summary, we began this project with an uncharacterized yeast mitochondrial protein. Through careful elucidation of its molecular function, we were able to generate a hypothesis about a possible link to human disease. This hypothesis was found to be true, enabling the identification of a human tumor susceptibility gene.
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